Stimulant
Ritalin Slow-Release (SR) 20 mg tablets.
Stimulants (also called psychostimulants[1]) are psychoactive drugs which induce temporary improvements in either mental or physical function or both. Examples of these kinds of effects may include enhanced alertness, wakefulness, and locomotion, among others. Due to their effects typically having an "up" quality to them, stimulants are also occasionally referred to as "uppers". Depressants or "downers", which decrease mental and/or physical function, are in stark contrast to stimulants and are considered to be their functional opposites. Stimulants are widely used throughout the world as prescription medicines and as illicit substances of recreational use or abuse.
Effects
Stimulants (Analeptics) produce a variety of different kinds of effects by enhancing the activity of the central and peripheral nervous systems. Common effects, which vary depending on the substance in question, may include enhanced alertness, awareness, wakefulness, endurance, productivity, and motivation, increased arousal, locomotion, heart rate, and blood pressure, and the perception of a diminished requirement for food and sleep. Many stimulants are also capable of improving mood and relieving anxiety, and some can even induce feelings of euphoria. It should be noted, however, that many of these drugs are also capable of causing anxiety, even the ones that may paradoxically reduce it to a degree at the same time. Stimulants exert their effects through a number of different pharmacological mechanisms, the most prominent of which include facilitation of norepinephrine (noradrenaline) and/or dopamine activity (e.g., via monoamine transporter inhibition or reversal[2]), adenosine receptor antagonism, and nicotinic acetylcholine receptor agonism.
Indications
Stimulants are used both individually and clinically for therapeutic purposes in the treatment of a number of indications, including the following:
- To counteract lethargy and fatigue throughout the day while at work or while doing other activities.
- To reduce sleepiness and to keep the person awake when necessary, as well as to treat narcolepsy.
- To decrease appetite and promote weight loss, as well as to treat obesity.
- To improve concentration and focus while at work or school, especially for those with attentional disorders such as ADHD.
- Occasionally, they are also used to treat clinical depression.
Types
Caffeine
Roasted coffee beans, the world's primary source of caffeine.
Caffeine is a mild stimulant compound that is found naturally in coffee, tea, and to a lesser degree, in cocoa or chocolate. It is included in many soft drinks, particularly energy drinks. Caffeine is the world's most widely used psychoactive drug and by far the most common stimulant. The vast majority (over 80%) of people in the United States consume caffeine on a daily basis. Few jurisdictions restrict its sale and use. Caffeine is also included in some medications, usually for the purpose of enhancing the effect of the primary ingredient, or reducing one of its side effects (especially drowsiness). Pure caffeine tablets are also widely available.
Nicotine
Nicotine is the active chemical constituent in tobacco, of which is available in many forms, including cigarettes, cigars, and chewing tobacco, among others. Nicotine is used widely throughout the world for its stimulating effects.
Amphetamines
Main article:
Amphetamine
A chart comparing the chemical structures of different
Amphetamines are a group of phenylethylamine stimulants such as amphetamine and methamphetamine. Like NDRIs, amphetamine increases the levels of norepinephrine and dopamine in the brain via reuptake inhibition; however, the more important mechanism by which amphetamines cause stimulation is through the direct release of these catecholamines from storage vesicles in cells. Amphetamines are known to cause elevated mood and euphoria as well as rebound depression and anxiety.[3]
Amphetamines are often used for their therapeutic effects; physicians occasionally prescribe amphetamines to treat major depression, where subjects do not respond well to tradition SSRI medications, and numerous studies have demonstrated the effectiveness of drugs such as Adderall in controlling symptoms associated with ADD/ADHD. In rare cases, ADD/ADHD patients who are not responding sufficiently to traditional amphetamines are prescribed Dextrorotary methamphetamine. Due to their availability and fast-acting effects, amphetamines are prime candidates for abuse [1].
MDMA ("Ecstasy")
Illicit tablets containing MDMA
Methylenedioxymethamphetamine (MDMA), known by its common street name "Ecstasy", is an illicit substance that typically comes in either tablet, capsule, or powder/crystal form. Medical application as a treatment for depression until 1985 when studies shown the unrecoverable seratonin levels when used as daily perscription. After one year of use, two tablets biweekly the levels were stable. MDMA is said to be a cross between an amphetamine stimulant and a psychedelic hallucinogen. Notably, MDMA is also unique and very popular for its entactogenic properties. The stimulant effects of MDMA include hypertension, anorexia (appetite loss), euphoria, social disinhibition, insomnia (or enhanced wakefulness), improved energy, increased arousal, and increased perspiration, among others.
Cocaine
Cocaine is made from the leaves of the coca shrub, which grows in the mountain regions of South American countries such as Bolivia, Colombia, and Peru. In Europe, North America, and in some part of Asia, the most common form of cocaine is a white crystalline powder. Cocaine is a stimulant but is not normally prescribed therapeutically for its stimulant properties, although it sees clinical use as a local anesthetic, particularly in ophthalmology. Most cocaine use is recreational and its abuse potential is high, and so its sale and possession are strictly controlled in most jurisdictions. Other tropane derivative drugs related to cocaine are also known such as troparil and lometopane but have not been widely sold or used recreationally.[4]
NRIs & NDRIs
These drugs inhibit the reuptake of norepinephrine and/or dopamine, resulting in increased extracellular levels and therefore enhanced neurotransmission, ultimately producing a stimulant effect. Many of these compounds are used as ADHD medications and antidepressants. The two most well known NDRIs are methylphenidate (Ritalin, Concerta) and bupropion (Wellbutrin, Zyban), and the two most well known NRIs are atomoxetine (Strattera) and reboxetine (Edronax). Many of these drugs have a considerably lower abuse potential in comparison to other stimulants like the amphetamines and cocaine.
Modafinil
Modafinil (Provigil/Alertec/Modavigil) is an analeptic drug approved by the (FDA) for the treatment of narcolepsy, shift work sleep disorder, and excessive daytime sleepiness associated with obstructive sleep apnea. Modafinil, like other stimulants, increases the release of monoamines but also elevates hypothalamic histamine levels, leading some researchers to consider Modafinil a "wakefulness promoting agent" rather than a classic amphetamine-like stimulant . Modafinil has been shown to be effective in the treatment of Attention-Deficit Hyperactivity Disorder (ADHD), depression, cocaine addiction, Parkinson's Disease, schizophrenia, shift workers' sleep disorder and disease-related fatigue.
Ampakines
Recently, there have been improvements in the area of stimulant pharmacology, producing a class of chemicals known as ampakines, or eugeroics, (good arousal). These stimulants tend to increase alertness without the peripheral (body) effects or addiction/tolerance/abuse potential of the traditional stimulants. They have minimal effect on sleep structure, and do not cause rebound hypersomnolence or "come down" effects. Ampakines such as ampalex and CX717 have been developed but are still in clinical trials and have not yet been sold commercially. Another compound with similar effects to these drugs is carphedon, which is sold as a general stimulant in Russia under the brand name Phenotropil.
Yohimbine
Yohimbine is a psychoactive drug of the tryptamine chemical class with stimulant and aphrodisiac effects.
Abuse
Abuse of central nervous system stimulants is common. Addiction to CNS stimulants can quickly lead to medical, psychiatric and psychosocial deterioration. Drug tolerance, dependence, sensitisation as well as a withdrawal syndrome can occur.[5]
Testing
The presence of stimulants in the body may be tested by a variety of procedures. Serum and urine are the common sources of testing material although saliva is sometimes used. Commonly used tests include chromatography, immunologic assay and mass spectrometry.[6]
See also
- Depressants
- Hallucinogens
External links
References
Stimulants |
|
Adamantanes |
Adaphenoxate • Adapromine • Amantadine • Bromantane • Chlodantane • Gludantane • Memantine • Midantane
|
|
Arylcyclohexylamines |
Benocyclidine • Dieticyclidine • Esketamine • Eticyclidine • Gacyclidine • Ketamine • Phencyclamine • Phencyclidine • Rolicyclidine • Tenocyclidine • Tiletamine
|
|
Benzazepines |
6-Br-APB • SKF-77434 • SKF-81297 • SKF-82958
|
|
Cholinergics |
A-84543 • A-366,833 • ABT-202 • ABT-418 • AR-R17779 • Altinicline • Anabasine • Arecoline • Cotinine • Cytisine • Dianicline • Epibatidine • Epiboxidine • GTS-21 • Ispronicline • Nicotine • PHA-543,613 • PNU-120,596 • PNU-282,987 • Pozanicline • Rivanicline • Sazetidine A • SIB-1553A • SSR-180,711 • TC-1698 • TC-1827 • TC-2216 • TC-5619 • Tebanicline • UB-165 • Varenicline • WAY-317,538
|
|
Convulsants |
Anatoxin-a • Bicuculline • DMCM • Flurothyl • Gabazine • Pentetrazol • Picrotoxin • Strychnine • Thujone
|
|
Eugeroics |
Adrafinil • Armodafinil • CRL-40941 • Modafinil
|
|
Oxazolines |
4-Methylaminorex • Aminorex • Clominorex • Cyclazodone • Fenozolone • Fluminorex • Pemoline • Thozalinone
|
|
Phenethylamines |
1-(4-Methylphenyl)-2-aminobutane • 2-Fluoroamphetamine • 2-Fluoromethamphetamine • 2-OH-PEA • 2-Phenyl-3-aminobutane • 2-Phenyl-3-methylaminobutane • 2,3-MDA • 3-Fluoroamphetamine • 3-Fluoroethamphetamine • 3-Fluoromethcathinone • 3-Methoxyamphetamine • 3-Methylamphetamine • 4-BMC • 4-Ethylamphetamine • 4-FA • 4-FMA • 4-MA • 4-MMA • 4-MTA • 6-FNE • Alfetamine • α-Ethylphenethylamine • Amfecloral • Amfepentorex • Amfepramone • Amidephrine • Amphetamine (Dextroamphetamine, Levoamphetamine) • Amphetaminil • Arbutamine • Atomoxetine (Tomoxetine) • β-Methylphenethylamine • β-Phenylmethamphetamine • Benfluorex • Benzphetamine • BDB (J) • BOH (Hydroxy-J) • BPAP • Buphedrone • Bupropion (Amfebutamone) • Butylone • Cathine • Cathinone • Chlorphentermine • Clenbuterol • Clobenzorex • Cloforex • Clortermine • D-Deprenyl • Denopamine • Dimethoxyamphetamine • Dimethylamphetamine • Dimethylcathinone (Dimethylpropion, Metamfepramone) • Dobutamine • DOPA (Dextrodopa, Levodopa) • Dopamine • Dopexamine • Droxidopa • EBDB (Ethyl-J) • Ephedrine • Epinephrine (Adrenaline) • Epinine (Deoxyepinephrine) • Etafedrine • Ethcathinone (Ethylpropion) • Ethylamphetamine (Etilamfetamine) • Ethylnorepinephrine (Butanefrine) • Ethylone • Etilefrine • Famprofazone • Fenbutrazate • Fencamine • Fencamfamine • Fenethylline • Fenfluramine (Dexfenfluramine) • Fenmetramide • Fenproporex • Flephedrone • Fludorex • Furfenorex • Gepefrine • HMMA • Hordenine • Ibopamine • IMP • Indanylamphetamine • Isoetarine • Isoprenaline (Isoproterenol) • L-Deprenyl (Selegiline) • Lefetamine • Lisdexamfetamine • Lophophine (Homomyristicylamine) • Manifaxine • MBDB (Methyl-J; "Eden") • MDA (Tenamfetamine) • MDBU • MDEA ("Eve") • MDMA ("Ecstasy", "Adam") • MDMPEA (Homarylamine) • MDOH • MDPR • MDPEA (Homopiperonylamine) • Mefenorex • Mephedrone • Mephentermine • Metanephrine • Metaraminol • Methamphetamine (Desoxyephedrine, Methedrine; Dextromethamphetamine, Levomethamphetamine) • Methoxamine • Methoxyphenamine • MMA • Methcathinone (Methylpropion) • Methedrone • Methoxyphenamine • Methylone • MMDA • MMDMA • MMMA • Morazone • Naphthylamphetamine • Nisoxetine • Norepinephrine (Noradrenaline) • Norfenefrine • Norfenfluramine • Normetanephrine • Octopamine • Orciprenaline • Ortetamine • Oxilofrine • Paredrine (Norpholedrine, Oxamphetamine, Mycadrine) • PBA • PCA • PHA • Pargyline • Pentorex (Phenpentermine) • Pentylone • Phendimetrazine • Phenmetrazine • Phenpromethamine • Phentermine • Phenylalanine • Phenylephrine (Neosynephrine) • Phenylpropanolamine • Pholedrine • PIA • PMA • PMEA • PMMA • PPAP • Prenylamine • Propylamphetamine • Pseudoephedrine • Radafaxine • Ropinirole • Salbutamol (Albuterol; Levosalbutamol) • Sibutramine • Synephrine (Oxedrine) • Theodrenaline • Tiflorex (Flutiorex) • Tranylcypromine • Tyramine • Tyrosine • Xamoterol • Xylopropamine • Zylofuramine
|
|
Piperazines |
2C-B-BZP • BZP • CM156 • DBL-583 • GBR-12783 • GBR-12935 • GBR-13069 • GBR-13098 • GBR-13119 • MeOPP • MBZP • Vanoxerine
|
|
Piperidines |
1-Benzyl-4-(2-(diphenylmethoxy)ethyl)piperidine • 2-Benzylpiperidine • 3,4-Dichloromethylphenidate • 4-Benzylpiperidine • 4-Methylmethylphenidate • Desoxypipradrol • Difemetorex • Diphenylpyraline • Ethylphenidate • Methylnaphthidate • Methylphenidate (Dexmethylphenidate) • Nocaine • Phacetoperane • Pipradrol • SCH-5472
|
|
Pyrrolidines |
α-PPP • α-PBP • α-PVP • MDPPP • MDPBP • MDPV • MPBP • MPHP • MPPP • MOPPP • Naphyrone • PEP • Prolintane • Pyrovalerone
|
|
Tropanes |
3-CPMT • 3-Pseudotropyl-4-fluorobenzoate • 4'-Fluorococaine • AHN-1055 • Altropane (IACFT) • Brasofensine • CFT (WIN 35,428) • β-CIT (RTI-55) • Cocaethylene • Cocaine • Dichloropane (RTI-111) • Difluoropine • FE-β-CPPIT • FP-β-CPPIT • Ioflupane (123I) • Norcocaine • PIT • PTT • RTI-31 • RTI-32 • RTI-51 • RTI-105 • RTI-112 • RTI-113 • RTI-117 • RTI-121 (IPCIT) • RTI-126 • RTI-150 • RTI-154 • RTI-171 • RTI-177 • RTI-183 • RTI-194 • RTI-202 • RTI-229 • RTI-241 • RTI-336 • RTI-354 • RTI-371 • RTI-386 • Salicylmethylecgonine • Tesofensine • Troparil (β-CPT, WIN 35,065-2) • Tropoxane • WF-23 • WF-33 • WF-60
|
|
Xanthines |
|
|
Others |
1-(Thiophen-2-yl)-2-aminopropane • 2-Amino-1,2-dihydronaphthalene • 2-Aminoindane • 2-Aminotetralin • 2-Diphenylmethylpyrrolidine • 2-MDP • 3,3-Diphenylcyclobutanamine • 5-(2-Aminopropyl)indole • 5-Iodo-2-aminoindane • AL-1095 • Amfonelic acid • Amineptine • Amiphenazole • Atipamezole • Bemegride • Benzydamine • BTQ • BTS 74,398 • Carphedon • Ciclazindol • Cilobamine • Clofenciclan • Cropropamide • Crotetamide • Diclofensine • Dimethocaine • Diphenylprolinol • Efaroxan • Etamivan • EXP-561 • Fenpentadiol • Feprosidnine • Gamfexine • Gilutensin • GYKI-52895 • Hexacyclonate • Idazoxan • Indanorex • Indatraline • JNJ-7925476 • JZ-IV-10 • Lazabemide • Leptacline • Levopropylhexedrine • Lomevactone • LR-5182 • Mazindol • Meclofenoxate • Medifoxamine • Mefexamide • Mesocarb • Methastyridone • Nefopam • Nikethamide • Nomifensine • O-2172 • Oxaprotiline • Phthalimidopropiophenone • PNU-99,194 • Propylhexedrine • PRC200-SS • Rasagiline • Rauwolscine • Rubidium chloride • Setazindol • Tametraline • Tandamine • Trazium • UH-232 • Yohimbine
|
|
See also |
|
Psychostimulants, agents used for ADHD, and nootropics (N06B) |
|
Centrally acting sympathomimetics |
|
|
Xanthine derivatives |
|
|
Glutamate receptor |
Racetams
|
Aniracetam • Nefiracetam • Noopept • Oxiracetam • Phenylpiracetam • Piracetam • Pramiracetam
|
|
Ampakines
|
CX-516 • CX-546 • CX-614 • CX-691 • CX-717 • IDRA-21 • LY-404,187 • LY-503,430 • PEPA • S-18986 • Sunifiram • Unifiram
|
|
|
Eugeroics / Benzhydryl compounds |
|
|
Histamine H3 receptor antagonists |
A-349,821 • ABT-239 • Ciproxifan • GSK-189,254
|
|
GABAA α5 inverse agonists |
α5IA • L-655,708 • PWZ-029 • Suritozole • TB-21007 • ZK-93426
|
|
Dopamine D1 receptor agonists |
A-77636 • Dihydrexidine • Dinapsoline • Doxanthrine • SKF-81297 • 6-Br-APB
|
|
α7 nicotinic agonists / PAMs |
AR-R17779 • PNU-282,987 • SSR-180,711
|
|
Prolyl endopeptidase inhibitors |
S-17092
|
|
Alpha-adrenergic agonists |
|
|
Other psychostimulants and nootropics |
Acetylcarnitine • Adafenoxate • Bifemelane • Carbenoxolone • Citicoline • Cyprodenate • Ensaculin • Idebenone • Ispronicline • Deanol • Dimebon • Fipexide • Leteprinim • Linopirdine • Meclofenoxate • Nizofenone • P7C3 • Pirisudanol • Pyritinol • Rubidium • Sulbutiamine • Taltirelin • Tricyanoaminopropene • Vinpocetine
|
|
|
|
dsrd (o, p, m, p, a, d, s), sysi/, spvo
|
|
|
|
|
Antiobesity agents/Anorectics (A08) |
|
Central |
Stimulants
|
4-Methylamphetamine • Amfecloral • Amfepentorex • Amfepramone • Aminorex • Amphetamine • Amphetaminil • Atomoxetine • Benfluorex • Benzphetamine • Bupropion • Cathine • Cathinone • Chlorphentermine • Ciclazindol • Clobenzorex • Cloforex • Clominorex • Clortermine • Dexfenfluramine • Dextroamphetamine • Dextromethamphetamine • Dexmethylphenidate • Difemetorex • Dimethylcathinone • Diphemethoxidine • Ephedrine • Ephedra • Ethylamphetamine • Etolorex • Fenbutrazate • Fencamfamine • Fenethylline • Fenfluramine • Fenproporex • Fludorex • Fluminorex • Furfenorex • Indanorex • Khat • Levopropylhexedrine • Lisdexamfetamine • Manifaxine • Mazindol • Mefenorex • Methamphetamine • Methylphenidate • Pemoline • Pentorex (Phenpentermine) • Phendimetrazine • Phenethylamine • Phenmetrazine • Phentermine • Phenylpropanolamine • Pipradrol • Prolintane • Propylhexedrine • Pseudoephedrine • Pyrovalerone • Radafaxine • Reboxetine • Setazindol • Sibutramine • Synephrine • Tesofensine • Viloxazine • Xylopropamine • Zylofuramine
|
|
|
Ibipinabant • Otenabant • Rimonabant • Surinabant • Taranabant
|
|
Others
|
|
|
|
Peripheral |
Cetilistat • Dinitrophenol • Oleoyl-Estrone • Orlistat • Simmondsin • Sterculia
|
|
|
|
Antidepressants (N06A) |
|
Specific reuptake inhibitors (RIs), enhancers (REs), and releasing agents (RAs) |
|
|
|
|
Serotonin-norepinephrine reuptake inhibitors (SNRIs)
|
|
|
Serotonin-norepinephrine-dopamine reuptake inhibitors (SNDRIs)
|
Brasofensine · BTS-74,398 · Cocaine · Diclofensine · DOV-21,947 · DOV-102,677 · DOV-216,303 · EXP-561 · Fezolamine · JNJ-7,925,476 · NS-2359 · PRC200-SS · Pridefrine · SEP-225,289 · SEP-227,162 · Tesofensine
|
|
Norepinephrine reuptake inhibitors (NRIs)
|
Amedalin · Atomoxetine/Tomoxetine · Binedaline · Ciclazindol · Daledalin · Esreboxetine · Lortalamine · Mazindol · Nisoxetine · Reboxetine · Talopram · Talsupram · Tandamine · Viloxazine
|
|
Dopamine reuptake inhibitors (DRIs)
|
Medifoxamine · Vanoxerine
|
|
Norepinephrine-dopamine reuptake inhibitors (NDRIs)
|
|
|
Norepinephrine-dopamine releasing agents (NDRAs)
|
|
|
Serotonin-norepinephrine-dopamine releasing agents (SNDRAs)
|
4-Methyl-αMT · αET/Etryptamine · αMT/Metryptamine
|
|
Selective serotonin reuptake enhancers (SSREs)
|
Tianeptine
|
|
Others
|
|
|
|
|
Receptor antagonists and/or reuptake inhibitors |
|
Serotonin antagonists and reuptake inhibitors (SARIs)
|
|
|
Noradrenergic and specific serotonergic antidepressants (NaSSAs)
|
Aptazapine · Esmirtazapine · Mianserin · Mirtazapine · Setiptiline/Teciptiline
|
|
Norepinephrine-dopamine disinhibitors (NDDIs)
|
Agomelatine
|
|
Serotonin modulators and stimulators (SMSs)
|
Lu AA21004
|
|
|
|
Tricyclic and tetracyclic antidepressants (TCAs/TeCAs) |
|
Tricyclics: Amezepine · Amineptine · Amitriptyline · Amitriptylinoxide · Azepindole · Butriptyline · Cianopramine · Clomipramine · Cotriptyline · Cyanodothiepin · Demexiptiline · Depramine/Balipramine · Desipramine · Dibenzepine · Dimetacrine · Dosulepin/Dothiepin · Doxepin · Enprazepine · Fluotracen · Hepzidine · Homopipramol · Imipramine · Imipraminoxide · Intriptyline · Iprindole · Ketipramine · Litracen · Lofepramine · Losindole · Mariptiline · Melitracen · Metapramine · Mezepine · Naranol · Nitroxazepine · Nortriptyline · Noxiptiline · Octriptyline · Opipramol · Pipofezine · Propizepine · Protriptyline · Quinupramine · Tampramine · Tianeptine · Tienopramine · Trimipramine; Tetracyclics: 7-OH-Amoxapine · Amoxapine · Aptazapine · Azipramine · Ciclazindol · Ciclopramine · Esmirtazapine · Loxapine · Maprotiline · Mazindol · Mianserin · Mirtazapine · Oxaprotiline · Setiptiline/Teciptiline
|
|
|
Monoamine oxidase inhibitors (MAOIs) |
|
Nonselective: Irreversible: Benmoxin · Echinopsidine · Iproclozide · Iproniazid · Isocarboxazid · Mebanazine · Metfendrazine · Nialamide · Octamoxin · Phenelzine · Pheniprazine · Phenoxypropazine · Pivalylbenzhydrazine · Safrazine · Tranylcypromine; Reversible: Caroxazone · Paraxazone; MAOA-Selective: Irreversible: Clorgyline; Reversible: Amiflamine · Bazinaprine · Befloxatone · Befol · Brofaromine · Cimoxatone · Esuperone · Harmala Alkaloids (Harmine, Harmaline, Tetrahydroharmine, Harman, Norharman, etc) · Methylene Blue · Metralindole · Minaprine · Moclobemide · Pirlindole · Sercloremine · Tetrindole · Toloxatone · Tyrima; MAOB-Selective: Irreversible: Ladostigil · Mofegiline · Pargyline · Rasagiline · Selegiline; Reversible: Lazabemide · Milacemide
|
|
|
Azapirones and other 5-HT1A receptor agonists |
|
Alnespirone · Aripiprazole · Befiradol · Buspirone · Eptapirone · Flesinoxan · Flibanserin · Gepirone · Ipsapirone · Oxaflozane · Tandospirone · Vilazodone · Zalospirone
|
|
|
|
|
Research compounds and miscellaneous agents |
|
5-HT4R agonists
|
RS-67,333 · SL65.0155
|
|
5-HT7R antagonists
|
Amisulpride
|
|
|
|
|
β3-Adrenoceptor agonists
|
Amibegron · Solabegron
|
|
|
|
|
|
|
|
COMT inhibitors
|
Entacapone · Tolcapone
|
|
CRF1R antagonists
|
Antalarmin · CP-154,526 · Pexacerfont · Pivagabine
|
|
D2/D3AR antagonists
|
Amisulpride · Sulpiride
|
|
D2/D3/D4R agonists
|
Piribedil · Pramipexole · Ropinirole · Rotigotine · Roxindole
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agomelatine · Melatonin · Ramelteon · Tasimelteon
|
|
NK1R antagonists
|
Aprepitant · Casopitant · Fosaprepitant · L-733,060 · Maropitant · Vestipitant
|
|
|
|
|
PDE4 inhibitors
|
Mesembrine (Kanna) · Rolipram
|
|
|
|
|
|
|
|
|
dsrd (o, p, m, p, a, d, s), sysi/, spvo
|
|
|
|
|
Anxiolytics (N05B) |
|
GABAA PAMs |
|
Adinazolam • Alprazolam • Bretazenil • Bromazepam • Camazepam • Chlordiazepoxide • Clobazam • Clonazepam • Clorazepate • Clotiazepam • Cloxazolam • Diazepam • Ethyl Loflazepate • Etizolam • Fludiazepam • Halazepam • Imidazenil • Ketazolam • Lorazepam • Medazepam • Nordazepam • Oxazepam • Pinazepam • Prazepam
|
|
Carbamates
|
Emylcamate • Mebutamate • Meprobamate (Carisoprodol, Tybamate) • Phenprobamate • Procymate
|
|
Nonbenzodiazepines
|
Abecarnil • Adipiplon • Alpidem • CGS-9896 • CGS-20625 • Divaplon • ELB-139 • Fasiplon • GBLD-345 • Gedocarnil • L-838,417 • NS-2664 • NS-2710 • Ocinaplon • Pagoclone • Panadiplon • Pipequaline • RWJ-51204 • SB-205,384 • SL-651,498 • Taniplon • TP-003 • TP-13 • TPA-023 • Y-23684 • ZK-93423
|
|
Pyrazolopyridines
|
Cartazolate • Etazolate • ICI-190,622 • Tracazolate
|
|
Others
|
|
|
|
α2δ VDCC Blockers |
|
|
5-HT1A Agonists |
Azapirones: Buspirone • Gepirone • Tandospirone; Others: Flesinoxan • Oxaflozane
|
|
H1 Antagonists |
Diphenylmethanes: Captodiame • Hydroxyzine; Others: Brompheniramine • Chlorpheniramine • Pheniramine
|
|
CRH1 Antagonists |
Antalarmin • CP-154,526 • Pexacerfont • Pivagabine
|
|
NK2 Antagonists |
GR-159,897 • Saredutant
|
|
MCH1 antagonists |
ATC-0175 • SNAP-94847
|
|
mGluR2/3 Agonists |
Eglumegad
|
|
mGluR5 NAMs |
Fenobam
|
|
TSPO agonists |
DAA-1097 • DAA-1106 • Emapunil • FGIN-127 • FGIN-143
|
|
σ1 agonists |
Afobazole • Opipramol
|
|
Others |
Benzoctamine • Carbetocin • Demoxytocin • Mephenoxalone • Mepiprazole • Oxanamide • Oxytocin • Promoxolane • Tofisopam • Trimetozine • WAY-267,464
|
|
#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III
|
|
dsrd (o, p, m, p, a, d, s), sysi/, spvo
|
|
|
|
|
Pharmacology: major drug groups |
|
Gastrointestinal tract/metabolism (A) |
|
|
Blood and blood forming organs (B) |
|
|
Cardiovascular system (C) |
|
|
Skin (D) |
Emollients • Cicatrizants • Antipruritics • Antipsoriatics • Medicated dressings
|
|
Genitourinary system (G) |
Hormonal contraception • Fertility agents • SERMs • Sex hormones
|
|
Endocrine system (H) |
Hypothalamic-pituitary hormones • Corticosteroids ( Glucocorticoids, Mineralocorticoids) • Sex hormones • Thyroid hormones/Antithyroid agents
|
|
Infections and infestations (J, P, QI) |
Antimicrobials: Antibacterials (Antimycobacterials) • Antifungals • Antivirals • Antiparasitics (Antiprotozoals, Anthelmintics, Ectoparasiticides) • IVIG • Vaccines
|
|
Malignant disease (L01-L02) |
Anticancer agents (Antimetabolites, Alkylating, Spindle poisons, Antineoplastic, Topoisomerase inhibitors)
|
|
Immune disease (L03-L04) |
|
|
Muscles, bones, and joints (M) |
|
|
Brain and nervous system (N) |
|
|
Respiratory system (R) |
|
|
Sensory organs (S) |
|
|
Other ATC (V) |
Antidotes • Contrast media • Radiopharmaceuticals • Dressings
|
|
Recreational drug use |
|
Major Recreational Drugs |
|
|
|
Depressants
|
|
|
Stimulants
|
|
|
Entactogens
|
|
|
Hallucinogens
|
Psychedelics
|
|
|
Dissociatives
|
|
|
Deliriants
|
|
|
|
|
|
|
|
|
Culture and Related Topics |
|
420 · Stoner Film · Spiritual Use of Cannabis · Medical Cannabis · Cannabis Cultivation · Cannabis smoking
|
|
Psychedelic
|
Art · Drug · Experience · Literature · Music
|
|
Other
|
Counterculture of the 1960s · Club Drug · Dance Party · Drug Tourism · Drug Paraphernalia · Hippie · Party and Play · Poly Drug Use · Rave · Self-medication · Sex and Drugs · Spiritual use of drugs
|
|
|
Problems with Drug Use |
Abuse · Addiction (Prevention · Opioid Replacement Therapy · Rehabilitation · Responsible Use) · Drug-related crime · Illegal Trade · Overdose
|
|
Legality of Drug Use |
International
|
1961 Narcotic Drugs · 1971 Psychotropic Substances · 1988 Drug Trafficking
|
|
State Level
|
Drug Policy (Prohibition · Supply reduction · Decriminalization) · Policy Reform (Liberalization · Harm Reduction · Demand Reduction)
|
|
Other
|
Designer Drug · Drug Possession · Drug Test · Hard and Soft Drugs · Narc · War on Drugs · Mexican Drug War
|
|
|
Lists of Countries by... |
Alcohol Consumption · Cannabis Legality (Annual Use · Lifetime Use) · Cocaine Use · Opiate Use · Cigarette Consumption
|
|